GLP-1s
New Study Reveals an Inconvenient Truth About Weight-Loss Drugs
GLP-1s deliver dramatic weight loss, but a new study reveals what happens when treatment stops and why weight often comes back fast.
These Nutrition Trends Will Rise & Fall in 2026, Experts Predict
Experts from at-home testing and nutrition company Zoe shared where they see industry trends going, for better or worse, in 2026.
The New Weight-Loss Problem Isn’t Access. It’s Burnout, Survey Finds
Weight loss is a top priority for Americans amid the rise of GLP-1s, but rising emotional strain suggests the system is starting to crack
Weight Watchers Goes All-In on GLP-1s With App Overhaul
The new Weight Watchers app combines GLP-1 prescriptions with personalized nutrition tools, coaching and strength training offerings.
Noom Eyes GLP-1s for Longevity, Not Just Weight Loss
Noom’s microdose GLP-1 program targets early metabolic risk and longevity, offering weight-loss drugs to adults with a BMI of 21 or higher.
Bodd Lands $15M for Body-Scanning Tech, With an Eye Toward GLP-1 Users
Bodd has raised $15 million to expand its body-scanning tech into the U.S. and U.K. while preparing pharmacy deployments for GLP-1 users.
Fitness Stakeholders Urge Strength Training for GLP-1 Users
Les Mills and ukactive are urging the healthcare and fitness sectors to promote strength training and adequate protein intake for people taking weight-loss drugs.
Beyond Botox: Med-Spas Find Their Next Chapter in Longevity
Med-spas are evolving into longevity clinics as GLP-1 users and wellness consumers seek regenerative treatments.
GLP-1s Could Reduce US Deaths by 9% in Best Case Scenario, Report Finds
Anti-obesity medications like GLP-1s have the potential to significantly reduce mortality in countries across the globe, per a new report.
HFA Backs Trump’s GLP-1 Medicare Expansion, Urges Exercise Coverage
The Health & Fitness Association has praised the expansion of Medicare to cover GLP-1 drugs and calls for the coverage of exercise programs.
